AHD Manhattan Midtown HCC — New York, New York

AHD Manhattan Midtown HCC is a clinical research site located in New York, New York, United States 10001.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

AHD Manhattan Midtown HCC has participated in 1 clinical trials.

Therapeutic areas: COVID-19, COVID-19 Vaccines, Immunogenicity, Vaccine.

Sponsors: Epividian.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AHD Manhattan Midtown HCC?

AHD Manhattan Midtown HCC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AHD Manhattan Midtown HCC conducted?

AHD Manhattan Midtown HCC has 1 clinical trials on record. Their work covers COVID-19, COVID-19 Vaccines, Immunogenicity, Vaccine.

Is AHD Manhattan Midtown HCC accredited by Crixeo Health?

AHD Manhattan Midtown HCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AHD Manhattan Midtown HCC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.